Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Rang în acțiuni #32325
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Preț acțiune
$0.88
Ultima sincronizare: 2026-08-17
Capitalizare de piață
$10.41M
Schimbare (1 zi)
-7.26%
Schimbare (1 an)
-50.56%
Țară
SG
Tranzacționează CytoMed Therapeutics Limited (GDTC)

Categorie

Istoric al prețului acțiunii pentru CytoMed Therapeutics Limited (GDTC)
Cel mai mare preț de închidere: $0.84 pe 2026-08-01

Cel mai mic preț de închidere: $3.48 pe 2023-04-01
Istoric al prețului acțiunii pentru CytoMed Therapeutics Limited din 2023 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$515.58 32.24%
US
$992.01 50.00%
NL
$109.41 -37.90%
AU
$736.64 6.99%
CH
$1.06K -7.10%
KR